$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Safety data on 19 vehicles for use in 1 month oral rodent pre‐clinical studies: administration of hydroxypropyl‐ß‐cyclodextrin causes renal toxicity

Journal of applied toxicology : JAT, v.36 no.1, 2016년, pp.140 - 150  

Healing, Guy (AstraZeneca, Drug Safety and Metabolism, Mereside, Alderley Park, Macclesfield, Cheshire, SK10 4TG, UK) ,  Sulemann, Tabassum (AstraZeneca, Pharmaceutical Development, Mereside, Alderley Park, Macclesfield, Cheshire, SK10 4TG, UK) ,  Cotton, Peter (AstraZeneca, Drug Safety and Metabolism, Mereside, Alderley Park, Macclesfield, Cheshire, SK10 4TG, UK) ,  Harris, Jayne (AstraZeneca, Drug Safety and Metabolism, 310 Darwin Building, Science Park, Cambridge, CB40 0WG, UK) ,  Hargreaves, Adam (AstraZeneca, Drug Safety and Metabolism, Mereside, Alderley Park, Macclesfield, Cheshire, SK10 4TG, UK) ,  Finney, Rowena (AstraZeneca, Drug Safety and Metabolism, Mereside, Alderley Park, Macclesfield, Cheshire, SK10 4TG, UK) ,  Kirk, Sarah (AstraZeneca, Discovery Sciences, Mereside, Alderley Park, Macclesfield, Cheshire, SK10 4TG, UK) ,  Schramm, Carolin (Ast) ,  Garner, Clare ,  Pivette, Perrine ,  Burdett, Lisa

Abstract AI-Helper 아이콘AI-Helper

AbstractPotential new drugs are assessed in pre‐clinical in vivo studies to determine their safety profiles. The drugs are formulated in vehicles suitable for the route of administration and the physicochemical properties of the drug, aiming to achieve optimal exposure in the test species. The...

주제어

참고문헌 (38)

  1. Anonymous . 1987 . Final report on the safety assessment of oleic acid, lauric acid, palmitic acid, myristic acid, and stearic acid . J. Am. Coll. Toxicol. 6 : 321 – 401 . 

  2. Brewster MA , Loftsson T . 2007 . Cyclodextrins as pharmaceutical solubilizers . Adv. Drug Deliver. Rev. 59 : 645 – 666 . 

  3. Delongeas JL , Vermeil de Conchard G , Beamonte A , Bertheux H , Spire C , Maisonneuve C , Becourt‐Lhote N , Goldfain‐Blanc F , Claude N . 2010 . Assessment of Labrasol®/Labrafil®/Transcutol® (4/4/2, v/v/v) as non‐clinical vehicle for poorly water‐soluble compounds after 4‐weeks oral toxicity study in Wistar rats . Regul. Toxicol. Pharm. 57 : 284 – 290 . 

  4. Duvinage C , Millecamps S , Sagnier A , Guffroy M , Sarsat J‐P , Belin V . 1996 . One‐month intravenous toxicity studies of poloxamer 188 in male Sprague‐Dawley rats and in beagle dogs . Toxicol. Lett. 88 : 101 . 

  5. European Medicines Agency (EMA) . Committee for Medicinal Products for Human Use (CHMP). 2013 . Guideline on the Use of Phthalates as Excipients in Human Medicinal Products – Draft . EMA/CHMP/SWP/362974/2012. 

  6. Gad SC , Cassidy CD , Aubert N , Spainhour B , Robbe H . 2006 . Nonclinical vehicles use in studies by multiple routes in multiple species . Int. J. Toxicol. 25 : 499 – 521 . 

  7. Gad SC . 2009 . Appendix E: Common vehicles for nonclinical evaluation of therapeutic agents . In Drug Safety Evaluation , 2nd edn , Gad SC (ed). John Wiley and Sons : New York ; 1140 – 1160 . 

  8. Gopinathan S , O'Neill E , Rodriguez LA , Champ R , Phillips M , Nouraldeen A , Wendt M , Wilson AGE , Kramer JA . 2013 . In vivo toxicology of excipients commonly employed in drug discovery in rats . J. Pharm. Toxicol. Methods. 68 : 284 – 295 . 

  9. Gould S , Scott R . 2005 . Hydroxypropyl‐beta‐cyclodextrin: A toxicology review . Food Chem. Toxicol. 43 : 1451 – 1459 . 

  10. Hamid KA , Katsumi H , Sakane T , Yamamoto A . 2009 . The effects of common solubilising agents on the intestinal membrane barrier functions and membrane toxicity in rats . Int. J. Pharmaceutics 379 : 100 – 108 . 

  11. Hermansky SJ , Neptun DA , Loughran KA , Leung HW . 1995 . Effects of polyethylene glycol 400 (PEG 400) following 13 weeks of gavage treatment in Fischer‐344 rats . Fd. Chem. Toxic. 33 : 139 – 149 . 

  12. Humberstone AJ , Charman WN . 1997 . Lipid‐based vehicles for the oral delivery of poorly soluble drugs . Adv. Drug Deliver. Rev. 25 : 103 – 128 . 

  13. ICH M3(R2) . 2009 . Non‐Clinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals . 

  14. Kitagawa H , Yano H , Fukuda Y . 1973 . Chronic toxicity of hydroxypropylmethylcellulose phthalate in rats . Pharmacometrics 7 : 689 – 701 . 

  15. LaKind JS , McKenna EA , Hubner RP , Tardiff RG . 1999 . A review of the comparative mammalian toxicity of ethylene glycol and propylene glycol . Cr. Rev. Toxicol. 29 : 331 – 365 . 

  16. Leuner C , Dressman J . 2000 . Improving drug solubility for oral delivery using solid dispersions . Eur. J. Pharm. Biopharm. 50 : 47 – 60 . 

  17. Li P , Zhao L , Yalkowsky SH . 1999 . Combined effect of co solvent and cyclodextrin on solubilization of nonpolar drugs . J. Pharm. Sci. 88 : 1107 – 1111 . 

  18. Loftsson T , Másson M , Brewster , ME . 2004 . Self‐association of cyclodextrins and cyclodextrin complexes . J. Pharm. Sci. 93 : 1091 – 1099 . 

  19. Lowry OH , Rosebrough NJ , Farr AL , Randall RJ . 1951 . Protein measurement with the folin phenol reagent . J. Biol. Chem. 193 : 265 – 275 . 

  20. MAK Value Documentation . 1998 . The MAK collection for occupational health and safety: Polyethylene glycol . In Occupational Toxicants . Vol. 10 , Wiley‐KH, Weinheim : Germany ; 248 – 270 DOI: 10.1002/3527600418.mb2532268kske0010 . 

  21. MAK Value Documentation . 2002 . The MAK Collection for Occupational Health and Safety: Oleic Acid . Wiley‐KH, Weinheim : Germany ; 246 – 266 DOI: 10.1002/3527600418.mb11280kske0017 . 

  22. McMartin K. 2009 . Are calcium oxalate crystals involved in the mechanism of acute renal failure in ethylene glycol poisoning? Clin. Toxicol. (Phila.) 47 : 859 – 869 . 

  23. Mullertz A , Ogbonna A , Ren S , Rades T . 2010 . New perspectives on lipid and surfactant based drug delivery systems for oral delivery of poorly soluble drugs . J. Pharm. Pharmacol. 62 : 1622 – 1636 . 

  24. Noel PRB , Barnett KC , Davies RE , Jolly DW , Leahy JS , Mawdesley‐Thomas LE , Shillam KWG , Swuires SPF , Street AE , Tucker WC , Worden AN . 1975 . The toxicity of dimethyl sulphoxide (DMSO) for the dog, pig, rat and rabbit . Toxicology 3 : 143 – 169 . 

  25. Pestel S , Martin H‐J , Maier G‐M , Guth B . 2006 . Effect of commonly used vehicles on gastrointestinal, renal and liver function in rats . J. Pharmacol. Toxicol. Methods 54 : 200 – 214 . 

  26. Pomara C , Fiore C , E'Errico S , Riezzo I , Fineschi V . 2008 . Calcium oxalate crystals in acute ethylene glycol poisoning: A confocal laser scanning microscope study in a fatal case . Clin. Toxicol. (Phila.) 46 : 322 – 324 . 

  27. Schladt L , Ivens I , Karbe E , Ruhl‐Fehlert C , Bomhard E . 1998 . Subacute oral toxicity of tetraethylene and ethylene glycol administered to Wistar rats . Exp. Toxic. Pathol. 50 : 257 – 265 . 

  28. Schwarz W . 1990 . PVP: A Critical Review of the Kinetics and Toxicology of Polyvinylpyrrolidone (povidone) . CRC Press . 

  29. Sellers RS , Antman M , Phillips J , Khan KN , Furst SM . 2005 . Effect of miglyol 812 on rats after 4 weeks of gavage as compared with methylcellulose/twen 80 . Drug Chem. Toxicol. 28 : 423 – 432 . 

  30. Singh‐Joy SD . 2008 . Safety assessment of poloxamers 101, 105, 108, 122, 123, 124, 181, 182, 183, 184, 185, 188, 212, 215, 217, 231, 234, 235, 237, 238, 282, 288, 331, 333, 334, 335, 338, 401, 402, 403 and 407, poloxamer 105 benzoate and poloxamer 182 dibenzoate as used in cosmetics . Int. J. Toxicol. 27 : 93 – 128 . 

  31. Som I , Bhatia K , Yasir M . 2012 . Status of surfactants as penetration enhancers in transdermal drug delivery . J. Pharm. Bioallied. Sci. 4 : 2 – 9 . 

  32. Stella VJ , Rajewski RA . 1997 . Cyclodextrins: their future in drug formulation and delivery . Pharm. Res. 14 : 556 – 567 . 

  33. Stokes AH , Kemp DC , Faiola B , Jordan HL , Merrill CL , Hailey JR , Brown RE , Bailey DW . 2013 . Effects of Solutol (Kolliphor) and Cremophor in Polyethylene Glycol 400 vehicle formulation in Sprague‐Dawley rats and beagle dogs . Int. J. Toxicol. 32 : 189 – 197 . 

  34. Strickley RG . 2004 . Solubilizing excipients in oral and injectable formulations . Pharm. Res. 21 : 201 – 230 . 

  35. Sullivan Jr DW , Gad SC , Julien M . 2014 . A review of the nonclinical safety of Transcutol®, a highly purified form of diethylene glycol monoethyl ether (DEGEE) used as a pharmaceutical excipient . Food Chem. Toxicol. 72 : 40 – 50 . 

  36. Sweetana S , Akers MJ . 1996 . Solubility principles and practices for parenteral drug dosage form development . PDA J. Pharm. Sci. Technol. 50 : 330 – 342 . 

  37. Thackaberry EA , Kopytek S , Sherrat P , Trouba K , McIntyre B . 2010 . Comprehensive investigation of hydroxypropyl methylcellulose, propylene glycol, polysorbate 80 and hydroxypropyl‐beta‐cyclodextrin for use in general toxicology studies . Toxicol. Sci. 117 : 485 – 492 . 

  38. Thackaberry EA . 2013 . Vehicle selection for nonclinical oral safety studies . Expert Opin. Drug Metab. Toxicol. 9 : 1635 – 1646 . 

관련 콘텐츠

이 논문과 함께 이용한 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로